Literature DB >> 15652749

p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.

Gustavo Baldassarre1, Barbara Belletti, Milena S Nicoloso, Monica Schiappacassi, Andrea Vecchione, Paola Spessotto, Andrea Morrione, Vincenzo Canzonieri, Alfonso Colombatti.   

Abstract

Emerging evidences suggest that cyclin-dependent kinase inhibitors (CKIs) can regulate cellular functions other than cell cycle progression, such as differentiation and migration. Here, we report that cytoplasmic expression of p27(kip1) affects microtubule (MT) stability following cell adhesion on extracellular matrix (ECM) constituents. This p27(kip1) activity is due to its ability to bind and impair the function of the MT-destabilizing protein stathmin. Accordingly, upregulation of p27(kip1) or downregulation of stathmin expression results in the inhibition of mesenchymal cell motility. Moreover, high stathmin and low cytoplasmic p27(kip1) expression correlate with the metastatic phenotype of human sarcomas in vivo. This study provides a functional link between proliferation and invasion of tumor cells based on diverse activities of p27(kip1) in different subcellular compartments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652749     DOI: 10.1016/j.ccr.2004.11.025

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  122 in total

1.  CXCR4-independent rescue of the myeloproliferative defect of the Gata1low myelofibrosis mouse model by Aplidin.

Authors:  Maria Verrucci; Alessandro Pancrazzi; Miguel Aracil; Fabrizio Martelli; Paola Guglielmelli; Maria Zingariello; Barbara Ghinassi; Emanuela D'Amore; José Jimeno; Alessandro M Vannucchi; Anna Rita Migliaccio
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

2.  Aneugenic activity of Op18/stathmin is potentiated by the somatic Q18-->e mutation in leukemic cells.

Authors:  Per Holmfeldt; Kristoffer Brännström; Sonja Stenmark; Martin Gullberg
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

3.  RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility.

Authors:  Michelle D Larrea; Feng Hong; Seth A Wander; Thiago G da Silva; David Helfman; Deborah Lannigan; Jeffrey A Smith; Joyce M Slingerland
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-22       Impact factor: 11.205

4.  New light on p27(kip1) in breast cancer.

Authors:  Barbara Belletti; Gustavo Baldassarre
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

5.  Transcriptional and post-transcriptional upregulation of p27 mediates growth inhibition of isorhapontigenin (ISO) on human bladder cancer cells.

Authors:  Guosong Jiang; Chao Huang; Jingxia Li; Haishan Huang; Jingjing Wang; Yawei Li; Fei Xie; Honglei Jin; Junlan Zhu; Chuanshu Huang
Journal:  Carcinogenesis       Date:  2018-03-08       Impact factor: 4.944

Review 6.  Meet me in the cytoplasm: A role for p27(Kip1) in the control of H-Ras.

Authors:  Gustavo Baldassarre; Barbara Belletti
Journal:  Small GTPases       Date:  2016-04-08

7.  MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.

Authors:  Adriana Sondermann; Flavia Maziero Andreghetto; Ana Carolina Bernardini Moulatlet; Elivane da Silva Victor; Marilia Germanos de Castro; Fábio Daumas Nunes; Lenine Garcia Brandão; Patricia Severino
Journal:  Clin Exp Metastasis       Date:  2015-05-26       Impact factor: 5.150

8.  Systematic analysis of the transcriptional switch inducing migration of border cells.

Authors:  Lodovica Borghese; Georgina Fletcher; Juliette Mathieu; Ann Atzberger; William C Eades; Ross L Cagan; Pernille Rørth
Journal:  Dev Cell       Date:  2006-04       Impact factor: 12.270

9.  p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

Authors:  Yiting Li; Manjula Nakka; Aaron J Kelly; Ching C Lau; Mark Krailo; Donald A Barkauskas; John M Hicks; Tsz-Kwong Man
Journal:  Cancer Res       Date:  2016-04-19       Impact factor: 12.701

10.  A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.

Authors:  Shuji Ogino; Katsuhiko Nosho; Yoshifumi Baba; Shoko Kure; Kaori Shima; Natsumi Irahara; Saori Toyoda; Li Chen; Gregory J Kirkner; Brian M Wolpin; Andrew T Chan; Edward L Giovannucci; Charles S Fuchs
Journal:  Am J Gastroenterol       Date:  2009-06-09       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.